S

Scribe Therapeutics

83 employees

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Life Science

Date founded

2017

Funding rounds raised

Total raised

$100M

from 10 investors over 10 rounds

S

Scribe Therapeutics raised undisclosed on May 17, 2023

Investors: Prevail Therapeutics

S

Scribe Therapeutics raised $100M on March 31, 2021

Investors: Wellington Management, RA Capital Management, L.P., T. Rowe Price, Andreessen Horowitz, Avoro Capital Advisors (formerly venBio Select Advisor), Perceptive Advisors, OrbiMed Advisors and Menlo Ventures

S

Scribe Therapeutics raised $20M on January 1, 2018

Investors: Andreessen Horowitz

FAQ